These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16103041)

  • 1. Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.
    Lee PH; Kim JS; Shin DH; Yoon SN; Huh K
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):372-4. PubMed ID: 16103041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
    Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
    Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac adrenergic nerve function in patients with cardiac syndrome X.
    Di Monaco A; Bruno I; Calcagni ML; Nerla R; Lamendola P; Barone L; Scalone G; Mollo R; Coviello I; Bagnato A; Sestito A; Giordano A; Lanza GA; Crea F
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):151-6. PubMed ID: 20010111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
    Kim JS; Lee PH; Lee KS; Park JW; Kim YI; Chung YA; Kim SH; Kim SH; Kim J; Choi YY; Kim HT
    Mov Disord; 2006 Nov; 21(11):1990-4. PubMed ID: 16991157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
    Tachibana K; Matsuura K; Shindo A; Matsuyama H; Ii Y; Taniguchi A; Tomimoto H
    Intern Med; 2020; 59(4):485-490. PubMed ID: 32062624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
    Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism.
    Lee PH; Yeo SH; Yong SW; Kim YJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1250-2. PubMed ID: 17557797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cardiac iodine-123 metaiodobenzylguanidine accumulation after drug therapy in a patient with Parkinson's disease.
    Kanzaki N; Sato K; Hayabara T
    Clin Nucl Med; 1997 Oct; 22(10):697-9. PubMed ID: 9343727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac sympathetic innervation imaging with myocardial MIBG scintigraphy].
    Genovese EA; Mallardo V; Cipullo S; Restuccia A; Galea D; D'Agosto G; Di Lanno I; Cappabianca S
    Recenti Prog Med; 2013; 104(7-8):356-60. PubMed ID: 24042407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
    Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E
    PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.
    Simula S; Vanninen E; Viitanen L; Kareinen A; Lehto S; Pajunen P; Syvänne M; Kuikka J; Laakso M; Hartikainen J
    J Nucl Med; 2002 Jan; 43(1):1-7. PubMed ID: 11801695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac sympathetic innervation in patients with ventricular arrhythmias: an assessment by 123I-metaiodobenzylguanidine scintigraphy].
    Loladze NV; Golitsyn SP; Samoĭlenko LE; Bekbosynova MS; Novikova DS; Nikitina DS; Nikitina TIa; Sergienko VB
    Kardiologiia; 2006; 46(5):27-34. PubMed ID: 16858351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Japanese standards for myocardial sympathetic and metabolic imaging in comparison with perfusion imaging.
    Matsuo S; Nakajima K; Yamashina S; Sakata K; Momose M; Hashimoto J; Kumita S; Kawano M; Okuda K
    Ann Nucl Med; 2009 Aug; 23(6):517-22. PubMed ID: 19521747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.